RSS

Depression

P1vital Products (PPL) has, in partnership with Canterbury and Coastal CCG, University of Kent, and the mental health charity MIND, been awarded £815,500 by Innovate UK to advance research to improve the treatment of depression. Read more

News

Drug delivery systems provider Aptar Pharma has announced that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. Read more

News

Scientists from the University of Vermont have found that wearable sensors could help detect anxiety and depression in young children. Read more

News

A new device designed to ‘revolutionise’ depression therapy has received CE mark approval and is now available across Europe. Read more

News